EP Patent

EP1486498A1 — Process and intermediates for growth hormone secretagogues

Assigned to Pfizer Products Inc · Expires 2004-12-15 · 21y expired

What this patent protects

This invention relates to a process for preparing compounds of the Formula wherein R 1 , R 2 and Pt are as defined in the specification, which are intermediates in the synthesis of certain growth hormone secretagogue compounds. This invention further relates to processes for p…

USPTO Abstract

This invention relates to a process for preparing compounds of the Formula wherein R 1 , R 2 and Pt are as defined in the specification, which are intermediates in the synthesis of certain growth hormone secretagogue compounds. This invention further relates to processes for preparing the growth hormone secretagogues. The invention also relates to the compound of Formula I wherein R 1 is H, R 2 is 2,2,2-trifluoromethyl and Pt is Boc.

Drugs covered by this patent

Patent Metadata

Patent number
EP1486498A1
Jurisdiction
EP
Classification
Expires
2004-12-15
Drug substance claim
No
Drug product claim
No
Assignee
Pfizer Products Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.